Priority Review Vouchers, FDA Funding Win In Omnibus Budget Deal
This article was originally published in The Pink Sheet Daily
FY 2016 funding bill is much higher than House and Senate appropriations committee totals.
You may also be interested in...
Omnibus legislation to fund the federal government for FY 2017 includes an increase in non-user fee funds, which should please stakeholders.
Stakeholders push Congress to renew program, although 21st Century Cures route unlikely.
In study mandated by FDASIA, GAO says there are advantages and disadvantages to switching to an electronic-only system for distributing drug label information, but offers no conclusions.